Mr. Speaker, I thank my colleague for her question.
In fact, that is a subject I did not address: the subject of confidentiality and everything relating to drugs that are approved, not approved and awaiting approval. There again, there are major roadblocks for ordinary consumers and people who want to know what they are consuming, who want to know how and why they consume it, and most importantly, if it is a drug, a therapeutic device or a surgical device, whether it is harmless or not.
Some day, and I hope that day comes soon, we are going to have to adopt some clear rules. There is a lot of talk about transparency, but we are going to have to get beyond talking and have some actual transparency.
We have been talking about transparency since I first came to this House, but everything is just as opaque everywhere, in all fields, as if no one had ever talked about transparency. People have to know, they have to be aware, they have to be sufficiently educated and informed about all the drugs and products they may take so they can make informed choices.
It is exactly the same thing with GMOs and therapeutic products. I referred earlier to essential oils in relation to Bill C-52. It is the same thing. Consumers have a right to know. Consumers seem to be very wise, because it is letters from consumers that are telling us to be careful and not let a minister do the work by himself and make decisions about a bill by himself.
This may not relate directly to the bill itself, but rather to the direction taken in the bill. If the minister can change the direction taken by a bill once it has been agreed to and passed, what point is there in sitting in this House, doing the essential work and drafting a bill like this to ensure that our fellow citizens, and consumers, have access to quality drugs and that their health is not in danger?
What point is there in doing all these studies and all this research, in bringing thousands of witnesses here, if the Minister of Health can ultimately get up one fine morning and say he no longer agrees with the direction taken in the bill and decide to change it? I think my colleague is right to be worried.